Status:
COMPLETED
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Measles
Mumps
Eligibility:
All Genders
12-23 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate that an investigational refrigerated vaccine with measles, mumps, rubella, and varicella is well tolerated and has similar immune response when compared to ...
Eligibility Criteria
Inclusion
- Healthy children 12-23 months of age
Exclusion
- Previously had measles, mumps, rubella, or varicella
- Compromised immune system
Key Trial Info
Start Date :
September 26 2002
Trial Type :
INTERVENTIONAL
End Date :
June 9 2003
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00092430
Start Date
September 26 2002
End Date
June 9 2003
Last Update
November 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.